Companies / Precigen, Inc.

Precigen, Inc.

Nasdaq: PGENCIK 1356090GERMANTOWN, MDprecigen.com ↗

Financials · FY2025

Revenue$9.68M
Net income$-250.64M
Total debt$93.88M
Cash$16.33M
Diluted EPS$-1.37
Shares outstanding358.0M

Ownership

358.0M shares outstanding · as of Jul 31, 2026
55.1%Insiders
Ownership
Insiders55.06%197,129,149
10%+ / strategic4.88%17,467,152
Institutions39.86%142,721,253
Public float0.20%717,693

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 13

View all →
Insider% of sharesShares
Randal J. KirkDirector · 10% owner
52.03%186,301,302
Sabzevari HelenCEOPresident and CEO · Director
1.05%3,768,872
Hassan FredDirector
0.35%1,243,239
Frank StevenDirector
0.34%1,226,391
Alvarez Cesar LDirector
0.22%782,909
Lehr Donald P.Chief Legal Officer
0.21%755,461
Turley James SDirector
0.19%685,417
Gupta Vinita DDirector
0.19%666,027
Thomasian Harry Jr.Chief Financial Officer
0.15%554,535
Shah Rutul RChief Operating Officer
0.14%497,751

Institutional holders 188

View all →
HolderValue% of shares
BlackRock, Inc.$97.74M4.79%
Patient Capital Management, LLC$78.06M5.22%
State Street Corporation$68.41M3.35%
Point72 Asset Management, L.P.$57.37M3.83%
Vanguard Group Inc$43.80M2.93%
Tang Capital Management, LLC$24.84M1.79%
Fmr LLC$19.45M1.30%
Geode Capital Management, LLC$17.86M1.29%
Diametric Capital, LP$16.08M1.07%
Driehaus Capital Management LLC$15.05M1.01%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Mar 30, 2026Randal J. Kirk
Director
SellCommon Stock$7.70M-2.3M
-15.99%
12,262,741
3.43% of shares
medium
Mar 30, 2026Randal J. Kirk
Director
SellCommon Stock$3.66M-1.1M
-1.36%
80,672,818
22.53% of shares
medium
Mar 30, 2026Randal J. Kirk
Director
SellCommon Stock$1.41M-426K
-11.26%
3,358,917
0.94% of shares
medium
Mar 30, 2026Randal J. Kirk
Director
SellCommon Stock$1.22M-371K
-10.28%
3,238,210
0.90% of shares
medium
Mar 30, 2026Randal J. Kirk
Director
SellCommon Stock$557.0K-169K
-10.59%
1,425,544
0.40% of shares
medium
May 28, 2026Sabzevari Helen
CEO
SellCommon Stock$519.9K-119K
-3.07%
3,768,872
1.05% of shares
medium
Mar 30, 2026Randal J. Kirk
Director
SellCommon Stock$501.8K-152K
-9.41%
1,463,571
0.41% of shares
medium
May 28, 2026Shah Rutul R
Executive
SellCommon Stock$186.2K-43K
-7.90%
497,751
0.14% of shares
medium

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Ares Trading SAPassive13G/A—17,467,152—
Patient Capital Management, LLCPassive13G/A———
Point72 Asset Management, L.P.Passive13G———
Point72 Asset Management, L.P.Passive13G/A———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
PGEN——46122T102—
PGEN——74017N105—